Health Care Declines as Abbott Labs, Elevance Slide on Earnings - Health Care Roundup

Dow Jones
2025/07/18

Health-care companies fell after a lackluster round of earnings.

Shares of medical-device maker Abbott Labs shares tumbled by more than 8% after it trimmed and narrowed its 2025 growth projections despite an increase in second-quarter sales.

Elevance shares slid after the health insurer slashed its projection for 2025 earnings, citing higher use of medical services by enrollees.

Bristol-Myers Squibb and Pfizer plan to sell the widely used blood thinner Eliquis directly to patients at a discounted cash price, a move that follows the Trump administration's pressure on the industry to cut drug prices.

 

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

July 17, 2025 17:23 ET (21:23 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10